BOULDER, Colo. , Jun 2, 2025 /PRNewswire/ -- Foresight Diagnostics, a leading diagnostics company specializing in ultra-sensitive minimal residual disease (MRD) detection, today announced a strategic, worldwide partnership with QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) to develop and commercialize a kit-based version of Foresight's CLARITY™ assay, with the goal of enabling global in vitro diagnostic (IVD) and companion diagnostic (CDx) applications in lymphoma and other hematological malignancies.

Exclusive Collection Designed to Honor Three of Caterpillar's Most Monumental Feats ROCKFORD, Mich. , June 2, 2025 /PRNewswire/ -- Cat® Footwear , a division of Wolverine World Wide, Inc. (NYSE: WWW ) and official footwear licensee of Caterpillar, is celebrating 100 years of innovation as Caterpillar Inc. marks its Centennial Anniversary in 2025.

BEAVERTON, Ore.--(BUSINESS WIRE)--NIKE, Inc. (NYSE:NKE) announced today that Michael Gonda will become Executive Vice President and Chief Communications Officer of NIKE, Inc., effective July 7, 2025. In this role, Gonda will lead the global communications organization, overseeing all facets of the communications strategy, including storytelling, corporate and brand reputation, issues management, and employee engagement. As a member of the company's Senior Leadership Team, Gonda will report to P.

SAN JOSE, Calif.--(BUSINESS WIRE)--Today, Adobe (Nasdaq:ADBE) announced it will release its second quarter fiscal year 2025 results after the market closes on Thursday, June 12, 2025, followed by a conference call with investors from 2-3 p.m. Pacific Time. The conference call will be streamed live on the Adobe Investor Relations Site. Following the call, a recording and related materials will be available on the site. Adobe uses its website as a channel of distribution of material company infor.

EXCLUSIVE: Mattel, the global toy and family entertainment company behind Barbie, today announced the formation of Mattel Studios, which will bring the company's film and television units together under the leadership of Robbie Brenner.

The U.S. government on Monday said it will require asset divestitures before allowing Keysight Technologies to complete its all-cash purchase of Spirent Communications.

Kemper is a widely known insurance name that has been performing very well. They have a rare reset-rate baby bond, symbol KMPB, which investors don't seem to understand. KMPB is quite undervalued. The reset-rate feature protects the bond against higher interest rates, which is rare in the world of long-term bonds.

APO teams up with major banks to expand private credit trading, aiming to boost liquidity and attract more capital.

NEW YORK, June 02, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Semler Scientific Inc. (“Semler” or the “Company”) (NASDAQ: SMLR). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

SMMT plunges 31% as its NSCLC drug shows strong PFS but misses statistical significance on survival data.

TCPC remains a sell due to ongoing NAV decline, weak earnings, and lack of meaningful new investment activity despite some portfolio improvements. While the 14% dividend yield is well-covered and distributions are likely safe, long-term capital destruction outweighs the income appeal. Non-accruals have improved and management reduced expenses and debt, but persistent headwinds from high interest rates limit upside potential.

NEW YORK, NY / ACCESS Newswire / June 2, 2025 / If you suffered a loss on your Compass Group Diversified Holdings, LLC (NYSE:CODI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/compass-diversified-lawsuit-submission-form?prid=151301&wire=1&utm_campaign=4 or contact Joseph E. Levi, Esq.

NEW YORK, June 02, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Savara Inc. (“Savara” or the “Company”) (NASDAQ: SVRA). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

NEW YORK, NY / ACCESS Newswire / June 2, 2025 / If you suffered a loss on your Krispy Kreme, Inc. (NASDAQ:DNUT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/krispy-kreme-inc-lawsuit-submission-form?prid=151302&wire=1&utm_campaign=17 or contact Joseph E. Levi, Esq.

IIPR holds more than $220 million in total liquidity, with a conservative 11% debt-to-assets ratio and sub-1x net debt-to-EBITDA. Tenant defaults led to a 13% QoQ AFFO drop to $55.3 million and a 6.5% revenue decline in Q1 FY 2025. The company re-leased ~1 million square feet in 18 months, replacing defaulted tenants with financially stronger operators.

SAN DIEGO, June 02, 2025 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP has launched an investigation into whether the board members of Blueprint Medicines Corporation (NASDAQ: BPMC) breached their fiduciary duties in connection with the proposed sale of the Company to Sanofi (NASDAQ: SNY).

Chinese cloud providers have been big buyers of U.S. artificial-intelligence hardware. Jefferies analysts are upbeat that the trend can continue despite trade-war pressures.

JPMorgan CEO Jamie Dimon said his gig isn't up at America's largest bank on Monday, insisting in an exclusive interview with Fox Business that his retirement is “several years away.” The bank's succession planning has been under scrutiny on Wall Street in recent months as Dimon approaches two decades in the top job.

NEW YORK, June 02, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Organon & Co. (“Organon” or the “Company”) (NYSE: OGN). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

NEW YORK, June 02, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of NeuroPace, Inc. (“NeuroPace” or the “Company”) (NASDAQ: NPCE). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.